Cero Therapeutics Holdings, Inc. (CERO): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$96.9K
As of 2023-12-31
$862.8K
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $96.9K | -79.6% | 2024-04-02, Balance as of period end |
| 2022-12-31 | $475.9K | -56.7% | 2024-04-02, Balance as of period end |
| 2021-12-31 | $1.10M | n/a | 2023-03-24, Balance as of period end |